Using immunoprecipitation in conjunction with real-time quaking-induced conversion (IP/RT-QuIC) Okuzumi and colleagues reported the ability to measure α-synuclein directly from the serum in patients with PD compared to normal controls [61]. The gene discussed is SNCA; the disease is Parkinson disease.